Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMID 1521979)

Published in Int J Epidemiol on August 01, 1992

Authors

J Crane1, N Pearce, C Burgess, K Woodman, B Robson, R Beasley

Author Affiliations

1: Department of Medicine, Wellington School of Medicine, New Zealand.

Associated clinical trials:

Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children | NCT02409277

Articles citing this

Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05

Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15

Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med (2005) 2.71

A confidential enquiry into deaths caused by asthma in an English health region: implications for general practice. Br J Gen Pract (1996) 2.22

Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ (1996) 2.20

First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax (1998) 1.90

Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax (2002) 1.81

Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49

Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital. Thorax (2007) 1.49

Characteristics and outcome for admissions to adult, general critical care units with acute severe asthma: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care (2004) 1.35

Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res (2000) 1.34

Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24

Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. CMAJ (1996) 1.19

Risk factors for readmission to hospital for asthma in childhood. Thorax (1994) 1.18

Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax (2002) 1.06

Risk factors for death in adults with severe asthma. Ann Allergy Asthma Immunol (2008) 0.95

Use of near fatal asthma for investigating asthma deaths. Thorax (1993) 0.93

The national review of asthma deaths: what did we learn and what needs to change? Breathe (Sheff) (2015) 0.87

Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS One (2011) 0.84

Burden of asthma in the hospital setting: an Australian analysis. Int J Clin Pract (2007) 0.82

Safety of long-acting beta-agonists: urgent need to clear the air remains. Eur Respir J (2009) 0.80

The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax (2005) 0.80

Articles by these authors

Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47

International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82

GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol (1996) 5.50

Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10

End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88

Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72

Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70

Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39

Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39

Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34

Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32

Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30

Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15

Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10

Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs. J Mol Biol (1987) 3.08

How much asthma is really attributable to atopy? Thorax (1999) 3.04

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02

COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97

The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65

The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61

Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61

Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53

Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36

Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27

The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27

Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25

Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19

Passive smoking and passive thinking. N Z Med J (1989) 2.17

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15

Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06

Baseline risk for asthma deaths. N Z Med J (1992) 2.02

An algorithm for secondary structure determination in proteins based on sequence similarity. FEBS Lett (1986) 2.01

Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99

Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95

Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94

Conformational properties of amino acid residues in globular proteins. J Mol Biol (1976) 1.93

Conferences point to growing concern about possible links between breast cancer, environment. CMAJ (1996) 1.93

Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88

Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88

Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87

Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84

Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81

Secondary structure prediction: combination of three different methods. Protein Eng (1988) 1.80

The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79

The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79

Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78

Biochemical effects of the hypoglycaemic compound pent--4-enoic acid and related non-hypoglycaemic fatty acids. Biochem J (1968) 1.78

Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77

Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76

The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72

Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68

Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67

Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66

Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J (2007) 1.64

International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64

Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62

Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med (2004) 1.60

Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis (2013) 1.57

The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J (1994) 1.57

Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56

Analysis of the code relating sequence to conformation in globular proteins. Development of a stereochemical alphabet on the basis of intra-residue information. Biochem J (1974) 1.56

Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy (2009) 1.55

Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54

Asthma in Maori people. N Z Med J (1992) 1.54

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51